GP120-W61D-35 is a gp120 sequence fragment incorporating the W61D mutation for targeted exploration of molecular recognition sites. Its structure helps clarify how specific residue changes influence envelope protein conformation. Researchers utilize it for mapping antigenic surfaces and probing stability constraints. The peptide supports mechanistic analysis of protein–protein interactions.
CAT No: H09192
1. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
2. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More